top of page
Anchor 1

We’re a talented group of scientists and entrepreneurs with a groundbreaking ability to 'see' and characterize new functional allosteric binding sites on proteins for drug development.

 

Our proprietary hydrogen-deuterium exchange LC-MS/MS FastHDX technology can take soluble proteins of interest and map out remote (allosteric) binding sites capable of modulating the active site (orthosteric) and rapidly deliver early allosteric hits against molecular targets with high target selectivity.

Allosteric binding site.jpg

© Allosterica Limited 2025 - all rights reserved

Allosterica and FastHDX are trademarks of Allosterica

Company registered in England & Wales under No. 13416711  VAT No. GB 460 5709 91

Registered Office:  21 Mole Business Park| Leatherhead | Surrey | KT22 7BA | UK

bottom of page